Prader-Willi syndrome, which strikes only 1 in 15,000 people, can cause learning issues, muscles weakness, a slow metabolism and an insatiable appetite.

Prader-Willi syndrome is stated to be a rare genetic neurodevelopmental disorder. Credit: Yuriy K/Shutterstock.© Yuriy K/Shutterstock.

People enrolled in the study were 4 years old or older with Prader-Willi syndrome and excessive hunger and had already been taking Vykart XR for an average of 3.3 years (range: 2.5 to 4.5 years).

Prader-Willi is different from conditions such as Down syndrome and autism, but, like autism, it is a spectrum disorder that can result in different issues in different children, Bystrak said.

Miller JL, Gevers E, Bridges N, et al. Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: A double-blind, placebo-controlled trial.

Federal regulators are clearing a first-of-its-kind treatment for symptoms of a rare neurodevelopmental disorder that is characterized by insatiable hunger. The Food and Drug Administration approved a ...

WOODBRIDGE, Va. (DC News Now) — May 15 marks National Prader-Willi Syndrome Awareness Day. For one Virginia father, the date is more than just a spot on the calendar — it’s a call to action.

Prader-Willi syndrome is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15, according to a press release from Soleno Therapeutics.

The Food and Drug Administration (FDA) has approved Vykat™ XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi ...

Diazoxide choline is the first drug indicated for hyperphagia in the rare genetic disorder. Prior to approval, people with Prader-Willi had to rely on strict dieting and off-label obesity medications.